Evidence review · standard
dsip metformin
Regeneration vs degeneration — where this fits
metformin represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether dsip mechanisms address underlying repair deficits.
What is known
Studied for sleep architecture and deep-sleep promotion.
Target condition: metformin. Body system: Metabolic tool; B12/mitochondrial concerns at chronic use — context dependent..
Logic chain
- dsip studied for sleep architecture and deep-sleep promotion..
- metformin involves metabolic tool; b12/mitochondrial concerns at chronic use — context dependent. dysfunction.
- If dsip reaches the affected tissue, it may shift the repair/breakdown balance.
- This chain is tested in animal or lab models only.
Parent peptide claims relevant here
- Rat studies show DSIP antiserum blocks sleep-deprivation-induced increases in SWS and GH release.
- 1992 double-blind study (n=16 chronic insomniacs) reported higher objective sleep efficiency and shorter latency with DSIP vs placebo, but no subjective change.
- 1981 study (n=6 insomniacs) found longer sleep duration, fewer interruptions, and more REM with DSIP, without daytime sedation.
- DSIP promotes sleep in rabbits, rats, cats, and mice.
- Limited user reports note subjective deep sleep increases on tracking without hangover effects.
Evidence tier
Preclinical — animal and in vitro studies only. No published human trials for this specific combination.
What we do not know
- Whether dsip reaches metformin tissue at functional concentrations
- Optimal dosing, route, and duration for this target
- Interaction with standard-of-care treatments for metformin
- Long-term safety profile in this population
Safety note
All peptide use for metformin is research-context only. Not medical advice. Consult a physician before any experimental compound.
Key evidence
system
Combinatorial mapping (transparent): dsip vs metformin — regen=0.17, degen=0.25, Δ=-0.08. Method: layer_relevance(0.20) × evidence_factor(0.85); catalog.degen_score for Metformin.
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
Machine verification:
/api/articles/dsip-metformin/contributionsAsk this article · 3 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.
What does the ledger say about this (system tier): "Combinatorial mapping (transparent): dsip vs metformin — regen=0.17, degen=0.25, Δ=-0.08. Method: layer_relevance(0.20) × evidence_factor(0.…"?
ask dsip-metformin claim c_map_dsip-metformin · paste includes §SELF
What can you answer from your catalogue about dsip metformin — and what remains open or unverified?
ask dsip-metformin gaps · paste includes §SELF
What are the strongest objections or counter-evidence on record against dsip metformin?
ask dsip-metformin objections · paste includes §SELF